A Study of DSP-2033 (Alvocidib) in Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
A Pilot Trial of Atorvastatin in Tumor Protein 53 (p53) -Mutant and p53 Wild-Type Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351
- Status
- COMPLETED
- Phase
- PHASE1
Milademetan Plus Quizartinib Combination Study in FLT3-ITD Mutant Acute Myeloid Leukemia (AML)
- Status
- TERMINATED
- Phase
- PHASE1
Detection of IDH2 Mutations and Monitoring Molecular Residual Disease in Patients With AML
- Status
- COMPLETED
- Phase
- N/A
Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide
- Status
- RECRUITING
- Phase
- PHASE1
Gemtuzumab Ozogamicin With G-CSF, Cladribine, Cytarabine & Mitoxantrone for Untreated AML & High-Grade Myeloid Neoplasm
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
Dec+Flu+Bu Conditioning Regimen for Elderly AML in CR Undergoing Allo-HSCT
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Ascorbic Acid Levels in MDS, AML, and CMML Patients
- Status
- COMPLETED
- Phase
- N/A
Dose-escalating Phase I Trial With GEM333 in Patients With Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Stem Cell Transplant to Treat Patients With Favorable or Intermediate Risk Minimal Residual Disease Negative Acute Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE2
IDH2 Inhibition Using Enasidenib as Maintenance Therapy for IDH2-mutant Myeloid Neoplasms Following Allogeneic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
A Prospective Randomized Comparison of HDAC Vs AD in the Induction Chemothrapy for AML.
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE3
IDH1 (AG 120) Inhibitor in Patients With IDH1 Mutated Myelodysplastic Syndrome
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Screening of IDH1 and IDH2 Gene Mutations in Adult Acute Myeloid Leukemia for Possible Targeted Therapy
- Status
- UNKNOWN
- Phase
- N/A
Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome
- Status
- SUSPENDED
- Phase
- PHASE1
Evaluating in Vivo AZA Incorporation in Mononuclear Cells Following Vidaza or CC486
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Evaluation of a Microfluidic Assay to Detect Minimal Residual Disease and Predict Relapse in AML Patients
- Status
- COMPLETED
- Phase
- N/A
Phase I Study of HMPL-523+Azacitidine in Elderly Patients With Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1